Clinical Papers - Oncology

The clinical papers featured below have been selected from all PET articles published during the week beginning Sunday, October 5, 2008. Click the title of the article to read the abstract on PubMed. If you or your institution subscribe to the journal in which the article was published, you should be able to download the full article. References for PET articles in allspecialties published during this week, including the articles listed below, may be downloaded in either MS Word or EndNote Library format from the Related Items box at the bottom of this page or from the PET References Archive.

Involved-Nodal Radiation Therapy As a Component of Combination Therapy for Limited-Stage Hodgkin’s Lymphoma: A Question of Field Size.

Campbell BA, Voss N, Pickles T, et al. 
J Clin Oncol. 2008;(Oct 6).


Role of Integrated PET-CT in Pelvic Lymph Node Staging of Cervical Cancer before Radical Hysterectomy.

Chung HH, Park NH, Kim JW, et al. 
Gynecol Obstet Invest. 2008;67:61-66(Oct 9).


Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.

Greco C, Nehmeh SA, Schoder H, et al. 
Am J Clin Oncol. 2008;31:439-445(Oct).


Combined (18)F-FDG-PET/CT Imaging in Radiotherapy Target Delineation for Head-and-Neck Cancer.

Guido A, Fuccio L, Rombi B, et al. 
Int J Radiat Oncol Biol Phys. 2008;(Sep 30).


High incidence of false-positive PET scans in patients with aggressive non-Hodgkin’s lymphoma treated with rituximab-containing regimens.

Han HS, Escalon MP, Hsiao B, et al. 
Ann Oncol. 2008;(Oct 7).


PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.

Heron DE, Andrade RS, Beriwal S, et al. 
Am J Clin Oncol. 2008;31:352-362(Aug).


Pretreatment Primary Tumor SUVmax Measured by FDG-PET and Pathologic Tumor Depth Predict for Poor Outcomes in Patients with Oral Cavity Squamous Cell Carcinoma and Pathologically Positive Lymph Nodes.

Liao CT, Chang JT, Wang HM, et al. 
Int J Radiat Oncol Biol Phys. 2008;(Oct 2).


The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma.

Muslimani AA, Farag HL, Francis S, et al. 
Am J Clin Oncol. 2008;31:409-412(Oct).


Point/counterpoint. PET/CT will become standard practice for radiotherapy simulation and planning.

Pan T, Chen L, Orton CG. 
Med Phys. 2008;35:3825-3827(Sep).


CT, MR, US,( 18)F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck.

Yoon DY, Hwang HS, Chang SK, et al. 
Eur Radiol. 2008;(Oct 9).


Diagnostic value of FDG-PET in recurrent colorectal carcinoma: A meta-analysis.

Zhang C, Chen Y, Xue H, et al. 
Int J Cancer. 2008;(Oct 9).


Related Items
Rich Text Format This week's clinical papers (Word file)
EndNote Library File This week's clinical papers (EndNote file)